Pfizer To Shed Four Products For FTC Blessing Of $17B Deal
The U.S. Federal Trade Commission on Monday blessed Pfizer Inc.'s acquisition of Hospira Inc. on the condition that the companies agreed to divest four products to U.S.-based generic company Alvogen Group...To view the full article, register now.
Already a subscriber? Click here to view full article